您好!欢迎访问上海易汇生物科技有限公司网站!
全国服务咨询热线:

18501609238

当前位置:首页 > 产品中心 > 基因测序 > 生物试剂盒 > Illumina KitsDX-102-1003Illumina 测序组合试剂盒DX-102-1003

Illumina 测序组合试剂盒DX-102-1003

简要描述:Illumina/MiSeqDx Cystic Fibrosis 139-Variant Assay (20 runs, 960 samples
上海易汇生物科技有限公司于17年正式代理Illumina公司基因芯片、二代测序NGS测序仪及相关测序试剂盒等产品
Sequencing Kits/ Microarray Kits
Illumina 测序组合试剂盒DX-102-1003

  • 产品型号:Illumina KitsDX-102-1003
  • 厂商性质:生产厂家
  • 更新时间:2019-05-31
  • 访  问  量:622

产品分类

Product Category

详细介绍

品牌illumina/美国因美纳货号DX-102-1003
规格1 kit供货周期两周
主要用途小型全基因组测序 组合试剂 试剂盒应用领域医疗卫生,化工,生物产业,制药

Illumina 测序组合试剂盒DX-102-1003

Illumina公司,致力于新一代测序和芯片技术的生产与开发,提供产品与应用资讯

Illumina/MiSeqDx Cystic Fibrosis 139-Variant Assay (20 runs, 960 samples)/DX-102-1003/1 Ea
产品编号: DX-102-1003
美  元  价: $0.00
会  员  价: 待定
品       牌: Illumina
产       地: 美国
公       司: Illumina, Inc.
产品分类: 其它>其它试剂>临床研究
公司分类: In Vitro Diagnostic (IVD) Products

 

Illumina公司创立于1998年4月,是遗传变异和生物学功能分析领域的优秀的产品、技术和服务供应商。通过帮助客户加快实现生物信息的采集、分析和应用,来改善人类健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products

上海易汇生物科技有限公司于17年正式代理Illumina公司基因芯片、二代测序NGS测序仪及相关测序试剂盒等产品

咨询illumina MiSeq测序试剂盒等产品欢迎您致电 上海易汇生物科技有限公司:1850 1609 238张经理

Product Highlights:

Compared to the current ACMG recommended cystic fibrosis variant panel, the MiSeqDx Cystic Fibrosis 139-Variant Assay offers:

  • Improved Detection Rates of Cystic Fibrosis-Causing Variants
    Detection of couples at risk increased from 72% to ~91%1
  • Reduced Additional Testing
    Highly accurate and reproducIBLe sequencing technology delivers dependable results

The MiSeqDx Cystic Fibrosis 139-Variant Assay is an FDA-cleared in vitro diagnostic (IVD) next-generation sequencing test designed to detect 139 CFTR variants as defined in the CFTR2 database. Other methods test only for those variants most commonly found in Caucasians, potentially missing CF-causing variants across broader ethnic groups. The MiSeqDx Cystic Fibrosis 139-Variant Assay offers the largest CF variant panel to overcome this bias and provide comprehensive detection across diverse demographics.2

Widely adopted next-generation sequencing

The MiSeqDx Cystic Fibrosis 139-Variant Assay provides a fully integrated molecular CF testing solution on the MiSeqDx instrument. Simply prepare libraries from 250 ng gDNA, load on to the MiSeqDx for sequencing using Illumina sequencing by synthesis (SBS) chemistry, and analyze with the user-friendly software. The automated workflow is quick and easy to perform, potentially minimizing human error.

A complete kit for library preparation and sequencing

The MiSeqDx Cystic Fibrosis 139-Variant Assay includes all index primers and reagents needed for library preparation, sample multiplexing, and sequencing in a single kit. MiSeqDx sequencing reagents are packaged in a convenient ready-to-use format, minimizing hands-on time and increasing uniformity in all tests. To accommodate a broad spectrum of testing needs, from small to large volumes, the assay is available in two kit configurations (2 or 20 runs).

Specifications:

Assay Time2.5 days
Hands-On Time3.5 hours
Input Quantity250 ng genomic DNA
System CompatibilityMiSeqDx
TechnologySequencing

Illumina 测序组合试剂盒DX-102-1003

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
上海易汇生物科技有限公司
地址:上海市奉贤区金大公路8218号1幢
邮箱:1006909781@qq.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息